Description
P2.06 Cost Analysis of Immunotherapy Using Dendritic Cells for Acute Myeloid Leukemia Patients
Article: P2.06 Cost Analysis of Immunotherapy Using Dendritic Cells for Acute Myeloid Leukemia Patients
€3.03
Related products
-
Article: Highlights in breast cancer
€3.03 Add to cart -
Article: Highlights in urologic cancer
€3.03 Add to cart -
Article: Highlights in squamous cell carcinoma of the head and neck
€3.03 Add to cart -
Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma
€3.03 Add to cart
Reviews
There are no reviews yet.